TATA NIFTY MIDSMALL HEALTHCARE INDEX FUND
Holdings
32
Concentrated
Top 10 weight
60%
Concentration
Strategy
Passive
Portfolio style
Equity
100%
Asset allocation
Portfolio
3Sectors6Large positions77.8%Top: Pharmaceuticals & Biotechnology0.0%Cash
Market-cap allocation
Mid cap65%
Small cap35%
Asset allocation
Equity100%
Top holdings
LAURUS LABS LTDEQUITY10.8%
LUPIN LTDEQUITY9.0%
FORTIS HEALTHCARE LTDEQUITY7.5%
AUROBINDO PHARMA LTDEQUITY6.7%
ALKEM LABORATORIES LTDEQUITY5.1%
GLENMARK PHARMACEUTICALS LTDEQUITY5.1%
BIOCON LTDEQUITY4.6%
MANKIND PHARMA LTDEQUITY4.3%
IPCA LABORATORIES LTDEQUITY3.7%
Sign in for free to unlock all 32 holdings →Portfolio insights
Portfolio read
- 100% equity.
- Large-cap exposure is 0%.
- Largest equity sector is Pharmaceuticals & Biotechnology at 77.8%.
Watchpoints
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 78%.
Generated from current fund metrics. Educational research only.
Peer comparison
Other funds in this category.
Explore comparable funds →Sector exposure
Showing top sectors from the current portfolio.
Healthcare Services21.3%